South Africa is running out of an essential medicine for treating very sick patients with tuberculosis (TB) and drug-resistant bacterial infections. Many hospitals are already out of stock.

How can EECA countries transition to domestic funding of harm reduction, HIV and TB responses?

A report about a patient with the most resistant strain of tuberculosis documented in the USA whose inability to access combination bedaquiline and delamanid compromised his care and created a public health risk.

We are pleased to introduce our new Weekly Newsletter! And invite you to subscribe to get weekly highlights for TB news, articles, and campaigns sent directly to your inbox.

Tuberculosis in the Age of Drug Resistance and HIV: Lessons from South Africa’s Experience, a report of the CSIS Global Health Policy Center

Advocates request that the EC immediately start working on a comprehensive EU-Eastern Partnership Policy Framework, which will pave the way for HIV, tuberculosis and viral hepatitis elimination in both the EU and the Eastern European Region.

Given the urgent need to address the MDR-TB epidemic in the Philippines, advocates urge for rapid delivery of the new treatment options to people with MDR-TB.

The number of tuberculosis cases detected and treated increased by 11 percent to reach 13.2 million.

Advocates call for the immediate scale up of rapid, cartridge-based nucleic acid amplification tests, such as GeneXpert MTB/RIF, to detect TB disease and rifampicin resistance.

Advocates urge Vertex to assure the timely and responsible development of drug candidate VXc-486 for tuberculosis.